Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
What You Missed On Wall Street On Friday » 16:08
07/01/22
07/01
16:08
07/01/22
16:08
ACCD

Accolade

$9.49 /

+2.11 (+28.59%)

, BGCP

BGC Partners

$3.50 /

+0.13 (+3.86%)

, MU

Micron

$53.47 /

-1.89 (-3.41%)

, FRG

Franchise Group

$32.49 /

-2.56 (-7.30%)

, KSS

Kohl's

$28.76 /

-6.94 (-19.44%)

, GM

General Motors

$32.16 /

+0.37 (+1.16%)

, STLA

Stellantis

$12.37 /

+0.005 (+0.04%)

, TM

Toyota

$155.28 /

+1.295 (+0.84%)

, LI

Li Auto

$37.55 /

-0.72 (-1.88%)

, NIO

Nio

$21.31 /

-0.445 (-2.05%)

, XPEV

XPeng

$30.18 /

-1.565 (-4.93%)

, TSM

TSMC

$76.89 /

-4.955 (-6.05%)

, FDX

FedEx

$223.14 /

-3.34 (-1.47%)

, CPNG

Coupang

$14.97 /

+2.22 (+17.41%)

, CMCSA

Comcast

$40.30 /

+1.06 (+2.70%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, PARA

Paramount

$25.15 /

+0.47 (+1.90%)

, PARAA

Paramount

$27.90 /

+0.66 (+2.42%)

, TSLA

Tesla

$678.69 /

+5.38 (+0.80%)

, MSFT

Microsoft

$258.68 /

+1.67 (+0.65%)

, AAPL

Apple

$138.28 /

+1.3 (+0.95%)

, C

Citi

$46.82 /

+0.795 (+1.73%)

, CVNA

Carvana

$21.90 /

-0.68 (-3.01%)

, NVTA

Invitae

$2.53 /

+0.1 (+4.12%)

, PACB

Pacific Biosciences

$4.45 /

+0.02 (+0.45%)

, DNA

Ginkgo Bioworks

$2.38 /

-0.005 (-0.21%)

, EHC

Encompass Health

$46.48 /

-9.53 (-17.01%)

, EHAB

Enhabit

$22.68 /

-0.32 (-1.39%)

, BORR

Borr Drilling

$4.34 /

-0.27 (-5.86%)

, ZIM

ZIM Integrated

$43.40 /

-3.745 (-7.94%)

, SJR

Shaw Communications

$29.80 /

+0.32 (+1.09%)

Get caught up quickly on…

ShowHide Related Items >><<
ZIM ZIM Integrated
$43.40 /

-3.745 (-7.94%)

XPEV XPeng
$30.18 /

-1.565 (-4.93%)

TSM TSMC
$76.89 /

-4.955 (-6.05%)

TSLA Tesla
$678.69 /

+5.38 (+0.80%)

TM Toyota
$155.28 /

+1.295 (+0.84%)

STLA Stellantis
$12.37 /

+0.005 (+0.04%)

SJR Shaw Communications
$29.80 /

+0.32 (+1.09%)

PARAA Paramount
$27.90 /

+0.66 (+2.42%)

PARA Paramount
$25.15 /

+0.47 (+1.90%)

PACB Pacific Biosciences
$4.45 /

+0.02 (+0.45%)

NVTA Invitae
$2.53 /

+0.1 (+4.12%)

NIO Nio
$21.31 /

-0.445 (-2.05%)

MU Micron
$53.47 /

-1.89 (-3.41%)

MSFT Microsoft
$258.68 /

+1.67 (+0.65%)

LI Li Auto
$37.55 /

-0.72 (-1.88%)

KSS Kohl's
$28.76 /

-6.94 (-19.44%)

GM General Motors
$32.16 /

+0.37 (+1.16%)

FRG Franchise Group
$32.49 /

-2.56 (-7.30%)

FDX FedEx
$223.14 /

-3.34 (-1.47%)

EHC Encompass Health
$46.48 /

-9.53 (-17.01%)

EHAB Enhabit
$22.68 /

-0.32 (-1.39%)

DNA Ginkgo Bioworks
$2.38 /

-0.005 (-0.21%)

CVNA Carvana
$21.90 /

-0.68 (-3.01%)

CPNG Coupang
$14.97 /

+2.22 (+17.41%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$40.30 /

+1.06 (+2.70%)

C Citi
$46.82 /

+0.795 (+1.73%)

BORR Borr Drilling
$4.34 /

-0.27 (-5.86%)

BGCP BGC Partners
$3.50 /

+0.13 (+3.86%)

ACCD Accolade
$9.49 /

+2.11 (+28.59%)

AAPL Apple
$138.28 /

+1.3 (+0.95%)

ACCD Accolade
$9.49 /

+2.11 (+28.59%)

07/01/22 Canaccord
Accolade price target lowered to $12 from $17 at Canaccord
05/02/22 Wells Fargo
Wells Fargo upgrades Accolade to Equal Weight, lowers price target to $6
05/02/22 Wells Fargo
Accolade upgraded to Equal Weight from Underweight at Wells Fargo
04/29/22 SVB Securities
Accolade downgraded to Market Perform from Outperform at SVB Leerink
BGCP BGC Partners
$3.50 /

+0.13 (+3.86%)

02/15/22 Credit Suisse
BGC Partners initiated with an Outperform at Credit Suisse
MU Micron
$53.47 /

-1.89 (-3.41%)

07/01/22 Evercore ISI
Evercore reiterates Outperform rating on Micron, sees EPS bottoming in February
07/01/22 Citi
Micron price target lowered to $80 from $85 at Citi
07/01/22 Cowen
Micron price target lowered to $70 from $90 at Cowen
07/01/22 Baird
Micron price target lowered to $60 from $90 at Baird
FRG Franchise Group
$32.49 /

-2.56 (-7.30%)

05/06/22 B. Riley
Franchise Group price target lowered to $63 from $65 at B. Riley
01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
12/08/21 Barrington
Franchise Group price target raised to $65 from $58 at Barrington
12/08/21 B. Riley
B. Riley remains buyer of Franchise Group after outlook tops estimates
KSS Kohl's
$28.76 /

-6.94 (-19.44%)

06/08/22 Citi
Target guidance cut bad for retail industry, says at Citi
05/23/22 Citi
Kohl's downgraded to Neutral from Buy at Citi
05/20/22 Morgan Stanley
Kohl's price target lowered to $38 from $42 at Morgan Stanley
05/20/22 Cowen
Kohl's price target lowered to $60 from $75 at Cowen
GM General Motors
$32.16 /

+0.37 (+1.16%)

06/16/22 Goldman Sachs
Goldman left Samsara analyst day with stronger conviction
06/07/22 Morgan Stanley
MP Materials price target raised to $46 from $42 at Morgan Stanley
06/01/22 Goldman Sachs
General Motors price target lowered to $46 from $59 at Goldman Sachs
06/01/22 Citi
General Motors price target lowered to $87 from $98 at Citi
STLA Stellantis
$12.37 /

+0.005 (+0.04%)

06/28/22 Exane BNP Paribas
Stellantis downgraded to Neutral from Outperform at Exane BNP Paribas
05/17/22 Bernstein
Stellantis initiated with a Market Perform at Bernstein
05/10/22 Berenberg
Stellantis initiated with a Buy at Berenberg
TM Toyota
$155.28 /

+1.295 (+0.84%)

05/31/22 JPMorgan
Toyota upgraded to Overweight from Neutral at JPMorgan
04/07/22 Jefferies
Toyota downgraded to Hold from Buy at Jefferies
03/03/22 Morgan Stanley
Other legacy automakers may follow Ford's lead, says Morgan Stanley
01/03/22 B. Riley
B. Riley calls Aspen Aerogels a top pick for 2022, ups price target
LI Li Auto
$37.55 /

-0.72 (-1.88%)

06/29/22 Morgan Stanley
Li Auto capital replenishment a strategic positive, says Morgan Stanley
06/21/22 Citi
Li Auto price target raised to $58.60 from $26.80 at Citi
05/11/22 Citi
Li Auto price target lowered to $26.80 from $51.50 at Citi
05/10/22 BofA
Li Auto price target lowered to $33 from $35 at BofA
NIO Nio
$21.31 /

-0.445 (-2.05%)

07/01/22 Nomura
Nio price target lowered to $25.80 from $51.50 at Nomura
06/30/22 HSBC
Nio price target raised to $28 from $26 at HSBC
06/27/22 Mizuho
Nio price target lowered to $48 from $55 at Mizuho
06/21/22 Citi
Nio price target lowered to $41.10 from $87 at Citi
XPEV XPeng
$30.18 /

-1.565 (-4.93%)

07/01/22 Nomura
XPeng downgraded to Neutral on short-term cash burn at Nomura
06/30/22 Nomura
XPeng downgraded to Neutral from Buy at Nomura
06/21/22 Citi
XPeng price target raised to $51.59 from $36.70 at Citi
05/24/22 JPMorgan
XPeng price target lowered to $35 from $42 at JPMorgan
TSM TSMC
$76.89 /

-4.955 (-6.05%)

06/21/22 Loop Capital
TSMC initiated with a Buy at Loop Capital
06/09/22 Susquehanna
TSMC on track to meet/exceed guidance, says Susquehanna
04/14/22 Credit Suisse
TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse
04/14/22 Erste Group
TSMC downgraded to Hold from Buy at Erste Group
FDX FedEx
$223.14 /

-3.34 (-1.47%)

07/01/22 Berenberg
FedEx downgraded to Hold from Buy at Berenberg
06/30/22 BofA
FedEx price target raised to $287 from $276 at BofA
06/30/22 KeyBanc
FedEx price target raised to $325 from $300 at KeyBanc
06/30/22 BMO Capital
FedEx price target raised to $280 from $270 at BMO Capital
CPNG Coupang
$14.97 /

+2.22 (+17.41%)

06/30/22 Credit Suisse
Coupang upgraded to Outperform at Credit Suisse following underperformance
06/30/22 Credit Suisse
Coupang upgraded to Outperform from Neutral at Credit Suisse
06/29/22 Morgan Stanley
Coupang initiated with an Overweight at Morgan Stanley
05/12/22 Mizuho
Coupang price target lowered to $18 from $28 at Mizuho
CMCSA Comcast
$40.30 /

+1.06 (+2.70%)

07/01/22 Daiwa
Comcast initiated with an Outperform at Daiwa
06/29/22 TD Securities
Comcast price target lowered to $60 from $65 at TD Securities
06/28/22 Scotiabank
Comcast assumed with an Outperform at Scotiabank (yesterday)
06/21/22 Truist
Magnite well positioned to partner with Netflix, says Truist
CMCSK Comcast
$58.00 /

+ (+0.00%)

05/23/22 Raymond James
Electronic Arts moves 'somewhat unexpected,' says Raymond James
04/14/22 Oppenheimer
Comcast price target lowered to $60 from $75 at Oppenheimer
03/23/22 Craig-Hallum
ComScore poised for share gains in local measurement, says Craig-Hallum
PARA Paramount
$25.15 /

+0.47 (+1.90%)

07/01/22 Daiwa
Paramount initiated with a Neutral at Daiwa
06/15/22 Evercore ISI
Disney showing good financial discipline with IPL renewal, says Evercore ISI
06/02/22 Wolfe Research
Paramount assumed at Underperform from Outperform at Wolfe Research
05/23/22 Citi
Paramount price target lowered to $44 from $47 at Citi
PARAA Paramount
$27.90 /

+0.66 (+2.42%)

TSLA Tesla
$678.69 /

+5.38 (+0.80%)

06/30/22 Goldman Sachs
Tesla could net $3B by opening up charging network, says Goldman
06/30/22 Wedbush
Wedbush expects Tesla June delivery numbers to be ugly, focus on 2H trajectory
06/28/22 Deutsche Bank
Deutsche cuts Tesla target, estimates below consensus into delivery report
06/27/22 Mizuho
Tesla price target lowered to $1,150 from $1,300 at Mizuho
MSFT Microsoft
$258.68 /

+1.67 (+0.65%)

06/29/22 Redburn
Microsoft initiated with a Buy at Redburn
06/27/22 William Blair
Okta not seeing backlash from security breach, says William Blair
06/24/22 Citi
Citi names top software picks with sector de-rating 'mostly done'
06/17/22 Morgan Stanley
Microsoft gaming build out hitting 'overdrive,' says Morgan Stanley
AAPL Apple
$138.28 /

+1.3 (+0.95%)

07/01/22 JPMorgan
Apple near-term estimates 'resilient' despite concerns, says JPMorgan
06/30/22 Tigress Financial
Tigress Financial reiterates Strong Buy on Apple, sees further upside in shares
06/30/22 Morgan Stanley
Morgan Stanley Asia checks 'mostly validate' Qualcomm-Apple baseband chatter
06/29/22 Wedbush
Apple iPhone demand holding up well despite fears, says Wedbush
C Citi
$46.82 /

+0.795 (+1.73%)

07/01/22 Oppenheimer
Oppenheimer says U.S. financial institutions 'dramatically undervalued'
07/01/22 Piper Sandler
Citi price target lowered to $62 from $70 at Piper Sandler
06/27/22 RBC Capital
Citi price target lowered to $60 from $65 at RBC Capital
06/24/22 Morgan Stanley
Citi price target lowered to $57 from $60 at Morgan Stanley
CVNA Carvana
$21.90 /

-0.68 (-3.01%)

06/30/22 JMP Securities
Carvana resumed with an Outperform at JMP Securities
06/28/22 Stifel
Carvana price target lowered to $34 from $48 at Stifel
06/13/22 Stephens
Carvana price target lowered to $38 from $100 at Stephens
05/19/22 BofA
Carvana price target lowered to $80 from $225 at BofA
NVTA Invitae
$2.53 /

+0.1 (+4.12%)

06/13/22 Benchmark
Invitae price target lowered to $6 from $13 at Benchmark
06/02/22 Piper Sandler
Invitae initiated with an Underweight at Piper Sandler
05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
PACB Pacific Biosciences
$4.45 /

+0.02 (+0.45%)

05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
DNA Ginkgo Bioworks
$2.38 /

-0.005 (-0.21%)

06/16/22 Jefferies
Ginkgo Bioworks price target lowered to $4.35 from $11.50 at Jefferies
05/18/22 BofA
BofA downgrades Ginkgo Bioworks to Underperform, halves target to $3
05/18/22 BofA
Ginkgo Bioworks downgraded to Underperform from Neutral at BofA
03/31/22 BTIG
Ginkgo Bioworks price target lowered to $6 from $12 at BTIG
EHC Encompass Health
$46.48 /

-9.53 (-17.01%)

06/21/22 Truist
Encompass Health price target lowered to $75 from $85 at Truist
06/21/22 Stephens
Encompass Health price target lowered to $74 from $78 at Stephens
06/17/22 Raymond James
Encompass Health price target lowered to $70 from $85 at Raymond James
06/08/22 RBC Capital
Encompass Health price target lowered to $82 from $85 at RBC Capital
EHAB Enhabit
$22.68 /

-0.32 (-1.39%)

BORR Borr Drilling
$4.34 /

-0.27 (-5.86%)

ZIM ZIM Integrated
$43.40 /

-3.745 (-7.94%)

07/01/22 BofA
ZIM Integrated downgraded to Underperform from Buy at BofA
06/17/22 JPMorgan
ZIM Integrated upgraded to Neutral from Underweight at JPMorgan
05/12/22 Citi
Citi opens 'positive Catalyst Watch' on ZIM Integrated into Q1
03/10/22 Clarksons Platou
ZIM Integrated downgraded to Neutral from Buy at Clarksons Platou
SJR Shaw Communications
$29.80 /

+0.32 (+1.09%)

06/28/22 Scotiabank
Shaw Communications assumed with a Sector Perform at Scotiabank (yesterday)
06/21/22 Canaccord
Shaw Communications upgraded to Buy from Hold at Canaccord
05/18/22 National Bank
Shaw upgraded to Outperform from Sector Perform at National Bank
05/06/22 Morgan Stanley
Shaw Communications named 'Catalyst Driven Idea' at Morgan Stanley
ZIM ZIM Integrated
$43.40 /

-3.745 (-7.94%)

XPEV XPeng
$30.18 /

-1.565 (-4.93%)

TSM TSMC
$76.89 /

-4.955 (-6.05%)

TSLA Tesla
$678.69 /

+5.38 (+0.80%)

TM Toyota
$155.28 /

+1.295 (+0.84%)

STLA Stellantis
$12.37 /

+0.005 (+0.04%)

SJR Shaw Communications
$29.80 /

+0.32 (+1.09%)

PARA Paramount
$25.15 /

+0.47 (+1.90%)

PACB Pacific Biosciences
$4.45 /

+0.02 (+0.45%)

NVTA Invitae
$2.53 /

+0.1 (+4.12%)

NIO Nio
$21.31 /

-0.445 (-2.05%)

MU Micron
$53.47 /

-1.89 (-3.41%)

MSFT Microsoft
$258.68 /

+1.67 (+0.65%)

LI Li Auto
$37.55 /

-0.72 (-1.88%)

KSS Kohl's
$28.76 /

-6.94 (-19.44%)

GM General Motors
$32.16 /

+0.37 (+1.16%)

FRG Franchise Group
$32.49 /

-2.56 (-7.30%)

FDX FedEx
$223.14 /

-3.34 (-1.47%)

EHC Encompass Health
$46.48 /

-9.53 (-17.01%)

DNA Ginkgo Bioworks
$2.38 /

-0.005 (-0.21%)

CVNA Carvana
$21.90 /

-0.68 (-3.01%)

CPNG Coupang
$14.97 /

+2.22 (+17.41%)

CMCSA Comcast
$40.30 /

+1.06 (+2.70%)

C Citi
$46.82 /

+0.795 (+1.73%)

BGCP BGC Partners
$3.50 /

+0.13 (+3.86%)

ACCD Accolade
$9.49 /

+2.11 (+28.59%)

AAPL Apple
$138.28 /

+1.3 (+0.95%)

  • 22
    Apr
  • 14
    Sep
  • 13
    Aug
TSM TSMC
$76.89 /

-4.955 (-6.05%)

TSLA Tesla
$678.69 /

+5.38 (+0.80%)

TM Toyota
$155.28 /

+1.295 (+0.84%)

STLA Stellantis
$12.37 /

+0.005 (+0.04%)

SJR Shaw Communications
$29.80 /

+0.32 (+1.09%)

PARAA Paramount
$27.90 /

+0.66 (+2.42%)

PARA Paramount
$25.15 /

+0.47 (+1.90%)

NIO Nio
$21.31 /

-0.445 (-2.05%)

MU Micron
$53.47 /

-1.89 (-3.41%)

MSFT Microsoft
$258.68 /

+1.67 (+0.65%)

LI Li Auto
$37.55 /

-0.72 (-1.88%)

KSS Kohl's
$28.76 /

-6.94 (-19.44%)

GM General Motors
$32.16 /

+0.37 (+1.16%)

FRG Franchise Group
$32.49 /

-2.56 (-7.30%)

FDX FedEx
$223.14 /

-3.34 (-1.47%)

EHC Encompass Health
$46.48 /

-9.53 (-17.01%)

CVNA Carvana
$21.90 /

-0.68 (-3.01%)

CPNG Coupang
$14.97 /

+2.22 (+17.41%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$40.30 /

+1.06 (+2.70%)

C Citi
$46.82 /

+0.795 (+1.73%)

AAPL Apple
$138.28 /

+1.3 (+0.95%)

TSM TSMC
$76.89 /

-4.955 (-6.05%)

TSLA Tesla
$678.69 /

+5.38 (+0.80%)

TM Toyota
$155.28 /

+1.295 (+0.84%)

STLA Stellantis
$12.37 /

+0.005 (+0.04%)

PARAA Paramount
$27.90 /

+0.66 (+2.42%)

PARA Paramount
$25.15 /

+0.47 (+1.90%)

PACB Pacific Biosciences
$4.45 /

+0.02 (+0.45%)

NVTA Invitae
$2.53 /

+0.1 (+4.12%)

MU Micron
$53.47 /

-1.89 (-3.41%)

MSFT Microsoft
$258.68 /

+1.67 (+0.65%)

LI Li Auto
$37.55 /

-0.72 (-1.88%)

GM General Motors
$32.16 /

+0.37 (+1.16%)

FRG Franchise Group
$32.49 /

-2.56 (-7.30%)

FDX FedEx
$223.14 /

-3.34 (-1.47%)

EHC Encompass Health
$46.48 /

-9.53 (-17.01%)

DNA Ginkgo Bioworks
$2.38 /

-0.005 (-0.21%)

CVNA Carvana
$21.90 /

-0.68 (-3.01%)

CPNG Coupang
$14.97 /

+2.22 (+17.41%)

CMCSA Comcast
$40.30 /

+1.06 (+2.70%)

C Citi
$46.82 /

+0.795 (+1.73%)

ACCD Accolade
$9.49 /

+2.11 (+28.59%)

AAPL Apple
$138.28 /

+1.3 (+0.95%)

ZIM ZIM Integrated
$43.40 /

-3.745 (-7.94%)

XPEV XPeng
$30.18 /

-1.565 (-4.93%)

TSM TSMC
$76.89 /

-4.955 (-6.05%)

TSLA Tesla
$678.69 /

+5.38 (+0.80%)

STLA Stellantis
$12.37 /

+0.005 (+0.04%)

PARAA Paramount
$27.90 /

+0.66 (+2.42%)

PARA Paramount
$25.15 /

+0.47 (+1.90%)

PACB Pacific Biosciences
$4.45 /

+0.02 (+0.45%)

NVTA Invitae
$2.53 /

+0.1 (+4.12%)

NIO Nio
$21.31 /

-0.445 (-2.05%)

MU Micron
$53.47 /

-1.89 (-3.41%)

MSFT Microsoft
$258.68 /

+1.67 (+0.65%)

LI Li Auto
$37.55 /

-0.72 (-1.88%)

KSS Kohl's
$28.76 /

-6.94 (-19.44%)

GM General Motors
$32.16 /

+0.37 (+1.16%)

FDX FedEx
$223.14 /

-3.34 (-1.47%)

EHC Encompass Health
$46.48 /

-9.53 (-17.01%)

DNA Ginkgo Bioworks
$2.38 /

-0.005 (-0.21%)

CVNA Carvana
$21.90 /

-0.68 (-3.01%)

CPNG Coupang
$14.97 /

+2.22 (+17.41%)

CMCSA Comcast
$40.30 /

+1.06 (+2.70%)

C Citi
$46.82 /

+0.795 (+1.73%)

BORR Borr Drilling
$4.34 /

-0.27 (-5.86%)

ACCD Accolade
$9.49 /

+2.11 (+28.59%)

AAPL Apple
$138.28 /

+1.3 (+0.95%)

On The Fly
What You Missed On Wall Street This Morning » 12:01
07/01/22
07/01
12:01
07/01/22
12:01
MU

Micron

$52.18 /

-3.18 (-5.74%)

, KSS

Kohl's

$28.08 /

-7.625 (-21.36%)

, FRG

Franchise Group

$32.45 /

-2.6 (-7.42%)

, GM

General Motors

$31.90 /

+0.11 (+0.35%)

, LI

Li Auto

$36.93 /

-1.34 (-3.50%)

, NIO

Nio

$21.28 /

-0.47 (-2.16%)

, XPEV

XPeng

$30.24 /

-1.505 (-4.74%)

, TSM

TSMC

$76.88 /

-4.965 (-6.07%)

, FDX

FedEx

$219.73 /

-6.75 (-2.98%)

, CPNG

Coupang

$14.43 /

+1.675 (+13.14%)

, PARA

Paramount

$24.84 /

+0.16 (+0.65%)

, PARAA

Paramount

$27.63 /

+0.39 (+1.43%)

, CMCSA

Comcast

$39.76 /

+0.52 (+1.33%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, TSLA

Tesla

$676.15 /

+2.84 (+0.42%)

, MSFT

Microsoft

$256.79 /

-0.22 (-0.09%)

, AAPL

Apple

$136.75 /

-0.23 (-0.17%)

, C

Citi

$46.14 /

+0.12 (+0.26%)

, UNPRF

Uniper

$14.50 /

-2 (-12.12%)

, ACCD

Accolade

$8.76 /

+1.38 (+18.70%)

, BGCP

BGC Partners

$3.41 /

+0.04 (+1.19%)

, SJR

Shaw Communications

$29.57 /

+0.09 (+0.31%)

, NVTA

Invitae

$2.64 /

+0.21 (+8.64%)

, PACB

Pacific Biosciences

$4.50 /

+0.07 (+1.58%)

, DNA

Ginkgo Bioworks

$2.45 /

+0.07 (+2.94%)

, BORR

Borr Drilling

$3.91 /

-0.705 (-15.29%)

, ZIM

ZIM Integrated

$43.05 /

-4.095 (-8.69%)

, EHC

Encompass Health

$46.26 /

-9.75 (-17.41%)

, EHAB

Enhabit

$22.44 /

-0.56 (-2.43%)

Get caught up quickly on…

ShowHide Related Items >><<
ZIM ZIM Integrated
$43.05 /

-4.095 (-8.69%)

XPEV XPeng
$30.24 /

-1.505 (-4.74%)

TSM TSMC
$76.88 /

-4.965 (-6.07%)

TSLA Tesla
$676.15 /

+2.84 (+0.42%)

SJR Shaw Communications
$29.57 /

+0.09 (+0.31%)

PARAA Paramount
$27.63 /

+0.39 (+1.43%)

PARA Paramount
$24.84 /

+0.16 (+0.65%)

PACB Pacific Biosciences
$4.50 /

+0.07 (+1.58%)

NVTA Invitae
$2.64 /

+0.21 (+8.64%)

NIO Nio
$21.28 /

-0.47 (-2.16%)

MU Micron
$52.18 /

-3.18 (-5.74%)

MSFT Microsoft
$256.79 /

-0.22 (-0.09%)

LI Li Auto
$36.93 /

-1.34 (-3.50%)

KSS Kohl's
$28.08 /

-7.625 (-21.36%)

GM General Motors
$31.90 /

+0.11 (+0.35%)

FRG Franchise Group
$32.45 /

-2.6 (-7.42%)

FDX FedEx
$219.73 /

-6.75 (-2.98%)

EHC Encompass Health
$46.26 /

-9.75 (-17.41%)

EHAB Enhabit
$22.44 /

-0.56 (-2.43%)

DNA Ginkgo Bioworks
$2.45 /

+0.07 (+2.94%)

CPNG Coupang
$14.43 /

+1.675 (+13.14%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.76 /

+0.52 (+1.33%)

C Citi
$46.14 /

+0.12 (+0.26%)

BORR Borr Drilling
$3.91 /

-0.705 (-15.29%)

BGCP BGC Partners
$3.41 /

+0.04 (+1.19%)

ACCD Accolade
$8.76 /

+1.38 (+18.70%)

AAPL Apple
$136.75 /

-0.23 (-0.17%)

MU Micron
$52.18 /

-3.18 (-5.74%)

07/01/22 Evercore ISI
Evercore reiterates Outperform rating on Micron, sees EPS bottoming in February
07/01/22 Citi
Micron price target lowered to $80 from $85 at Citi
07/01/22 Cowen
Micron price target lowered to $70 from $90 at Cowen
07/01/22 Baird
Micron price target lowered to $60 from $90 at Baird
KSS Kohl's
$28.08 /

-7.625 (-21.36%)

06/08/22 Citi
Target guidance cut bad for retail industry, says at Citi
05/23/22 Citi
Kohl's downgraded to Neutral from Buy at Citi
05/20/22 Morgan Stanley
Kohl's price target lowered to $38 from $42 at Morgan Stanley
05/20/22 Cowen
Kohl's price target lowered to $60 from $75 at Cowen
FRG Franchise Group
$32.45 /

-2.6 (-7.42%)

05/06/22 B. Riley
Franchise Group price target lowered to $63 from $65 at B. Riley
01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
12/08/21 Barrington
Franchise Group price target raised to $65 from $58 at Barrington
12/08/21 B. Riley
B. Riley remains buyer of Franchise Group after outlook tops estimates
GM General Motors
$31.90 /

+0.11 (+0.35%)

06/16/22 Goldman Sachs
Goldman left Samsara analyst day with stronger conviction
06/07/22 Morgan Stanley
MP Materials price target raised to $46 from $42 at Morgan Stanley
06/01/22 Goldman Sachs
General Motors price target lowered to $46 from $59 at Goldman Sachs
06/01/22 Citi
General Motors price target lowered to $87 from $98 at Citi
LI Li Auto
$36.93 /

-1.34 (-3.50%)

06/29/22 Morgan Stanley
Li Auto capital replenishment a strategic positive, says Morgan Stanley
06/21/22 Citi
Li Auto price target raised to $58.60 from $26.80 at Citi
05/11/22 Citi
Li Auto price target lowered to $26.80 from $51.50 at Citi
05/10/22 BofA
Li Auto price target lowered to $33 from $35 at BofA
NIO Nio
$21.28 /

-0.47 (-2.16%)

07/01/22 Nomura
Nio price target lowered to $25.80 from $51.50 at Nomura
06/30/22 HSBC
Nio price target raised to $28 from $26 at HSBC
06/27/22 Mizuho
Nio price target lowered to $48 from $55 at Mizuho
06/21/22 Citi
Nio price target lowered to $41.10 from $87 at Citi
XPEV XPeng
$30.24 /

-1.505 (-4.74%)

07/01/22 Nomura
XPeng downgraded to Neutral on short-term cash burn at Nomura
06/30/22 Nomura
XPeng downgraded to Neutral from Buy at Nomura
06/21/22 Citi
XPeng price target raised to $51.59 from $36.70 at Citi
05/24/22 JPMorgan
XPeng price target lowered to $35 from $42 at JPMorgan
TSM TSMC
$76.88 /

-4.965 (-6.07%)

06/21/22 Loop Capital
TSMC initiated with a Buy at Loop Capital
06/09/22 Susquehanna
TSMC on track to meet/exceed guidance, says Susquehanna
04/14/22 Credit Suisse
TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse
04/14/22 Erste Group
TSMC downgraded to Hold from Buy at Erste Group
FDX FedEx
$219.73 /

-6.75 (-2.98%)

07/01/22 Berenberg
FedEx downgraded to Hold from Buy at Berenberg
06/30/22 BofA
FedEx price target raised to $287 from $276 at BofA
06/30/22 KeyBanc
FedEx price target raised to $325 from $300 at KeyBanc
06/30/22 BMO Capital
FedEx price target raised to $280 from $270 at BMO Capital
CPNG Coupang
$14.43 /

+1.675 (+13.14%)

06/30/22 Credit Suisse
Coupang upgraded to Outperform at Credit Suisse following underperformance
06/30/22 Credit Suisse
Coupang upgraded to Outperform from Neutral at Credit Suisse
06/29/22 Morgan Stanley
Coupang initiated with an Overweight at Morgan Stanley
05/12/22 Mizuho
Coupang price target lowered to $18 from $28 at Mizuho
PARA Paramount
$24.84 /

+0.16 (+0.65%)

07/01/22 Daiwa
Paramount initiated with a Neutral at Daiwa
06/15/22 Evercore ISI
Disney showing good financial discipline with IPL renewal, says Evercore ISI
06/02/22 Wolfe Research
Paramount assumed at Underperform from Outperform at Wolfe Research
05/23/22 Citi
Paramount price target lowered to $44 from $47 at Citi
PARAA Paramount
$27.63 /

+0.39 (+1.43%)

CMCSA Comcast
$39.76 /

+0.52 (+1.33%)

07/01/22 Daiwa
Comcast initiated with an Outperform at Daiwa
06/29/22 TD Securities
Comcast price target lowered to $60 from $65 at TD Securities
06/28/22 Scotiabank
Comcast assumed with an Outperform at Scotiabank (yesterday)
06/21/22 Truist
Magnite well positioned to partner with Netflix, says Truist
CMCSK Comcast
$58.00 /

+ (+0.00%)

05/23/22 Raymond James
Electronic Arts moves 'somewhat unexpected,' says Raymond James
04/14/22 Oppenheimer
Comcast price target lowered to $60 from $75 at Oppenheimer
03/23/22 Craig-Hallum
ComScore poised for share gains in local measurement, says Craig-Hallum
TSLA Tesla
$676.15 /

+2.84 (+0.42%)

06/30/22 Goldman Sachs
Tesla could net $3B by opening up charging network, says Goldman
06/30/22 Wedbush
Wedbush expects Tesla June delivery numbers to be ugly, focus on 2H trajectory
06/28/22 Deutsche Bank
Deutsche cuts Tesla target, estimates below consensus into delivery report
06/27/22 Mizuho
Tesla price target lowered to $1,150 from $1,300 at Mizuho
MSFT Microsoft
$256.79 /

-0.22 (-0.09%)

06/29/22 Redburn
Microsoft initiated with a Buy at Redburn
06/27/22 William Blair
Okta not seeing backlash from security breach, says William Blair
06/24/22 Citi
Citi names top software picks with sector de-rating 'mostly done'
06/17/22 Morgan Stanley
Microsoft gaming build out hitting 'overdrive,' says Morgan Stanley
AAPL Apple
$136.75 /

-0.23 (-0.17%)

07/01/22 JPMorgan
Apple near-term estimates 'resilient' despite concerns, says JPMorgan
06/30/22 Tigress Financial
Tigress Financial reiterates Strong Buy on Apple, sees further upside in shares
06/30/22 Morgan Stanley
Morgan Stanley Asia checks 'mostly validate' Qualcomm-Apple baseband chatter
06/29/22 Wedbush
Apple iPhone demand holding up well despite fears, says Wedbush
C Citi
$46.14 /

+0.12 (+0.26%)

07/01/22 Oppenheimer
Oppenheimer says U.S. financial institutions 'dramatically undervalued'
07/01/22 Piper Sandler
Citi price target lowered to $62 from $70 at Piper Sandler
06/27/22 RBC Capital
Citi price target lowered to $60 from $65 at RBC Capital
06/24/22 Morgan Stanley
Citi price target lowered to $57 from $60 at Morgan Stanley
UNPRF Uniper
$14.50 /

-2 (-12.12%)

04/28/22 UBS
Uniper price target lowered to EUR 25 from EUR 39 at UBS
04/08/22 JPMorgan
Uniper price target lowered to EUR 32 from EUR 35.50 at JPMorgan
04/04/22 RBC Capital
Uniper price target lowered to EUR 30 from EUR 40 at RBC Capital
03/17/22 Citi
Uniper upgraded to Buy from Neutral at Citi
ACCD Accolade
$8.76 /

+1.38 (+18.70%)

07/01/22 Canaccord
Accolade price target lowered to $12 from $17 at Canaccord
05/02/22 Wells Fargo
Wells Fargo upgrades Accolade to Equal Weight, lowers price target to $6
05/02/22 Wells Fargo
Accolade upgraded to Equal Weight from Underweight at Wells Fargo
04/29/22 SVB Securities
Accolade downgraded to Market Perform from Outperform at SVB Leerink
BGCP BGC Partners
$3.41 /

+0.04 (+1.19%)

02/15/22 Credit Suisse
BGC Partners initiated with an Outperform at Credit Suisse
SJR Shaw Communications
$29.57 /

+0.09 (+0.31%)

06/28/22 Scotiabank
Shaw Communications assumed with a Sector Perform at Scotiabank (yesterday)
06/21/22 Canaccord
Shaw Communications upgraded to Buy from Hold at Canaccord
05/18/22 National Bank
Shaw upgraded to Outperform from Sector Perform at National Bank
05/06/22 Morgan Stanley
Shaw Communications named 'Catalyst Driven Idea' at Morgan Stanley
NVTA Invitae
$2.64 /

+0.21 (+8.64%)

06/13/22 Benchmark
Invitae price target lowered to $6 from $13 at Benchmark
06/02/22 Piper Sandler
Invitae initiated with an Underweight at Piper Sandler
05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
PACB Pacific Biosciences
$4.50 /

+0.07 (+1.58%)

05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
DNA Ginkgo Bioworks
$2.45 /

+0.07 (+2.94%)

06/16/22 Jefferies
Ginkgo Bioworks price target lowered to $4.35 from $11.50 at Jefferies
05/18/22 BofA
BofA downgrades Ginkgo Bioworks to Underperform, halves target to $3
05/18/22 BofA
Ginkgo Bioworks downgraded to Underperform from Neutral at BofA
03/31/22 BTIG
Ginkgo Bioworks price target lowered to $6 from $12 at BTIG
BORR Borr Drilling
$3.91 /

-0.705 (-15.29%)

ZIM ZIM Integrated
$43.05 /

-4.095 (-8.69%)

07/01/22 BofA
ZIM Integrated downgraded to Underperform from Buy at BofA
06/17/22 JPMorgan
ZIM Integrated upgraded to Neutral from Underweight at JPMorgan
05/12/22 Citi
Citi opens 'positive Catalyst Watch' on ZIM Integrated into Q1
03/10/22 Clarksons Platou
ZIM Integrated downgraded to Neutral from Buy at Clarksons Platou
EHC Encompass Health
$46.26 /

-9.75 (-17.41%)

06/21/22 Truist
Encompass Health price target lowered to $75 from $85 at Truist
06/21/22 Stephens
Encompass Health price target lowered to $74 from $78 at Stephens
06/17/22 Raymond James
Encompass Health price target lowered to $70 from $85 at Raymond James
06/08/22 RBC Capital
Encompass Health price target lowered to $82 from $85 at RBC Capital
EHAB Enhabit
$22.44 /

-0.56 (-2.43%)

ZIM ZIM Integrated
$43.05 /

-4.095 (-8.69%)

XPEV XPeng
$30.24 /

-1.505 (-4.74%)

UNPRF Uniper
$14.50 /

-2 (-12.12%)

TSM TSMC
$76.88 /

-4.965 (-6.07%)

TSLA Tesla
$676.15 /

+2.84 (+0.42%)

SJR Shaw Communications
$29.57 /

+0.09 (+0.31%)

PARA Paramount
$24.84 /

+0.16 (+0.65%)

PACB Pacific Biosciences
$4.50 /

+0.07 (+1.58%)

NVTA Invitae
$2.64 /

+0.21 (+8.64%)

NIO Nio
$21.28 /

-0.47 (-2.16%)

MU Micron
$52.18 /

-3.18 (-5.74%)

MSFT Microsoft
$256.79 /

-0.22 (-0.09%)

LI Li Auto
$36.93 /

-1.34 (-3.50%)

KSS Kohl's
$28.08 /

-7.625 (-21.36%)

GM General Motors
$31.90 /

+0.11 (+0.35%)

FRG Franchise Group
$32.45 /

-2.6 (-7.42%)

FDX FedEx
$219.73 /

-6.75 (-2.98%)

EHC Encompass Health
$46.26 /

-9.75 (-17.41%)

DNA Ginkgo Bioworks
$2.45 /

+0.07 (+2.94%)

CPNG Coupang
$14.43 /

+1.675 (+13.14%)

CMCSA Comcast
$39.76 /

+0.52 (+1.33%)

C Citi
$46.14 /

+0.12 (+0.26%)

BGCP BGC Partners
$3.41 /

+0.04 (+1.19%)

ACCD Accolade
$8.76 /

+1.38 (+18.70%)

AAPL Apple
$136.75 /

-0.23 (-0.17%)

  • 14
    Sep
  • 13
    Aug
UNPRF Uniper
$14.50 /

-2 (-12.12%)

TSM TSMC
$76.88 /

-4.965 (-6.07%)

TSLA Tesla
$676.15 /

+2.84 (+0.42%)

SJR Shaw Communications
$29.57 /

+0.09 (+0.31%)

PARAA Paramount
$27.63 /

+0.39 (+1.43%)

PARA Paramount
$24.84 /

+0.16 (+0.65%)

NIO Nio
$21.28 /

-0.47 (-2.16%)

MU Micron
$52.18 /

-3.18 (-5.74%)

MSFT Microsoft
$256.79 /

-0.22 (-0.09%)

LI Li Auto
$36.93 /

-1.34 (-3.50%)

KSS Kohl's
$28.08 /

-7.625 (-21.36%)

GM General Motors
$31.90 /

+0.11 (+0.35%)

FDX FedEx
$219.73 /

-6.75 (-2.98%)

EHC Encompass Health
$46.26 /

-9.75 (-17.41%)

CPNG Coupang
$14.43 /

+1.675 (+13.14%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.76 /

+0.52 (+1.33%)

C Citi
$46.14 /

+0.12 (+0.26%)

AAPL Apple
$136.75 /

-0.23 (-0.17%)

XPEV XPeng
$30.24 /

-1.505 (-4.74%)

TSM TSMC
$76.88 /

-4.965 (-6.07%)

TSLA Tesla
$676.15 /

+2.84 (+0.42%)

PARAA Paramount
$27.63 /

+0.39 (+1.43%)

PARA Paramount
$24.84 /

+0.16 (+0.65%)

PACB Pacific Biosciences
$4.50 /

+0.07 (+1.58%)

NVTA Invitae
$2.64 /

+0.21 (+8.64%)

MU Micron
$52.18 /

-3.18 (-5.74%)

MSFT Microsoft
$256.79 /

-0.22 (-0.09%)

LI Li Auto
$36.93 /

-1.34 (-3.50%)

KSS Kohl's
$28.08 /

-7.625 (-21.36%)

GM General Motors
$31.90 /

+0.11 (+0.35%)

FDX FedEx
$219.73 /

-6.75 (-2.98%)

EHC Encompass Health
$46.26 /

-9.75 (-17.41%)

DNA Ginkgo Bioworks
$2.45 /

+0.07 (+2.94%)

CPNG Coupang
$14.43 /

+1.675 (+13.14%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.76 /

+0.52 (+1.33%)

C Citi
$46.14 /

+0.12 (+0.26%)

ACCD Accolade
$8.76 /

+1.38 (+18.70%)

AAPL Apple
$136.75 /

-0.23 (-0.17%)

ZIM ZIM Integrated
$43.05 /

-4.095 (-8.69%)

XPEV XPeng
$30.24 /

-1.505 (-4.74%)

TSM TSMC
$76.88 /

-4.965 (-6.07%)

TSLA Tesla
$676.15 /

+2.84 (+0.42%)

PARAA Paramount
$27.63 /

+0.39 (+1.43%)

PARA Paramount
$24.84 /

+0.16 (+0.65%)

PACB Pacific Biosciences
$4.50 /

+0.07 (+1.58%)

NVTA Invitae
$2.64 /

+0.21 (+8.64%)

NIO Nio
$21.28 /

-0.47 (-2.16%)

MU Micron
$52.18 /

-3.18 (-5.74%)

MSFT Microsoft
$256.79 /

-0.22 (-0.09%)

LI Li Auto
$36.93 /

-1.34 (-3.50%)

KSS Kohl's
$28.08 /

-7.625 (-21.36%)

GM General Motors
$31.90 /

+0.11 (+0.35%)

FDX FedEx
$219.73 /

-6.75 (-2.98%)

EHC Encompass Health
$46.26 /

-9.75 (-17.41%)

DNA Ginkgo Bioworks
$2.45 /

+0.07 (+2.94%)

CPNG Coupang
$14.43 /

+1.675 (+13.14%)

CMCSA Comcast
$39.76 /

+0.52 (+1.33%)

C Citi
$46.14 /

+0.12 (+0.26%)

BORR Borr Drilling
$3.91 /

-0.705 (-15.29%)

ACCD Accolade
$8.76 /

+1.38 (+18.70%)

AAPL Apple
$136.75 /

-0.23 (-0.17%)

Thursday
Hot Stocks
Pacific Biosciences, Invitae amend development and commercialization agreement » 16:19
06/30/22
06/30
16:19
06/30/22
16:19
PACB

Pacific Biosciences

$4.43 /

-0.135 (-2.96%)

, NVTA

Invitae

$2.43 /

-0.095 (-3.76%)

In a regulatory filing,…

In a regulatory filing, Pacific Biosciences of California (PACB) disclosed that on June 24, PacBio entered into an amended and restated development and commercialization agreement with Invitae Corporation (NVTA). "The Amended and Restated Agreement amended and restated the existing Development and Commercialization Agreement, effective as of January 12, 2021, as amended by Amendment No. 1 to Development and Commercialization Agreement, entered into on June 3, 2021, by and between PacBio and Invitae. The parties anticipate that in connection with the Amended and Restated Agreement, PacBio will continue to receive feedback, input and insight from Invitae in connection with the intended development of its new sequencing systems; however, such feedback will not be contractually required and Invitae has no contractual right to participate in decisions regarding the development program for such new sequencing systems. PacBio's development plans for such new sequencing systems will be at PacBio's discretion and pursuant to its own internal processes and programs. Invitae will not be contractually obligated to reimburse PacBio for development costs under the Amended and Restated Agreement. In consideration of the non-refundable Development Costs paid by Invitae to PacBio pursuant to the Original Agreement, PacBio will provide Invitae with credits and discounted pricing in connection with Invitae's anticipated purchase of currently available and in-development sequencing systems. In addition, subject to certain conditions, Invitae will be entitled to most favored pricing for the Company's Sequel IIe systems and certain in-development systems. There can be no assurances that the in-development sequencing systems will continue to be developed, be successfully developed or become available for commercial sale. PacBio and Invitae each may terminate the Amended and Restated Agreement if the other party remains in material breach of the Amended and Restated Agreement following a cure period to remedy such breach," the filing states.

ShowHide Related Items >><<
PACB Pacific Biosciences
$4.43 /

-0.135 (-2.96%)

NVTA Invitae
$2.43 /

-0.095 (-3.76%)

PACB Pacific Biosciences
$4.43 /

-0.135 (-2.96%)

05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
NVTA Invitae
$2.43 /

-0.095 (-3.76%)

06/13/22 Benchmark
Invitae price target lowered to $6 from $13 at Benchmark
06/02/22 Piper Sandler
Invitae initiated with an Underweight at Piper Sandler
05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
PACB Pacific Biosciences
$4.43 /

-0.135 (-2.96%)

NVTA Invitae
$2.43 /

-0.095 (-3.76%)

PACB Pacific Biosciences
$4.43 /

-0.135 (-2.96%)

NVTA Invitae
$2.43 /

-0.095 (-3.76%)

PACB Pacific Biosciences
$4.43 /

-0.135 (-2.96%)

NVTA Invitae
$2.43 /

-0.095 (-3.76%)

Over a week ago
Conference/Events
Pacific Biosciences participates in a conference call with JPMorgan » 12:50
06/17/22
06/17
12:50
06/17/22
12:50
PACB

Pacific Biosciences

$4.32 /

+0.265 (+6.54%)

Growth Life Science Tools…

Growth Life Science Tools & Diagnostics Analyst Qin holds a conference call with CEO Henry on June 17 at 1 pm hosted by JPMorgan.

ShowHide Related Items >><<
PACB Pacific Biosciences
$4.32 /

+0.265 (+6.54%)

PACB Pacific Biosciences
$4.32 /

+0.265 (+6.54%)

05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
PACB Pacific Biosciences
$4.32 /

+0.265 (+6.54%)

PACB Pacific Biosciences
$4.32 /

+0.265 (+6.54%)

PACB Pacific Biosciences
$4.32 /

+0.265 (+6.54%)

Conference/Events
Pacific Biosciences participates in a conference call with JPMorgan » 04:55
06/17/22
06/17
04:55
06/17/22
04:55
PACB

Pacific Biosciences

$4.06 /

-0.235 (-5.48%)

Growth Life Science Tools…

Growth Life Science Tools & Diagnostics Analyst Qin holds a conference call with CEO Henry on June 17 at 1 pm hosted by JPMorgan.

ShowHide Related Items >><<
PACB Pacific Biosciences
$4.06 /

-0.235 (-5.48%)

PACB Pacific Biosciences
$4.06 /

-0.235 (-5.48%)

05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
PACB Pacific Biosciences
$4.06 /

-0.235 (-5.48%)

PACB Pacific Biosciences
$4.06 /

-0.235 (-5.48%)

PACB Pacific Biosciences
$4.06 /

-0.235 (-5.48%)

Conference/Events
Pacific Biosciences participates in a conference call with JPMorgan » 17:05
06/10/22
06/10
17:05
06/10/22
17:05
PACB

Pacific Biosciences

$4.27 /

-0.27 (-5.95%)

Growth Life Science Tools…

Growth Life Science Tools & Diagnostics Analyst Qin holds a conference call with CEO Henry on June 17 at 1 pm hosted by JPMorgan.

ShowHide Related Items >><<
PACB Pacific Biosciences
$4.27 /

-0.27 (-5.95%)

PACB Pacific Biosciences
$4.27 /

-0.27 (-5.95%)

05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
PACB Pacific Biosciences
$4.27 /

-0.27 (-5.95%)

PACB Pacific Biosciences
$4.27 /

-0.27 (-5.95%)

PACB Pacific Biosciences
$4.27 /

-0.27 (-5.95%)

Over a month ago
Recommendations
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler » 21:15
05/15/22
05/15
21:15
05/15/22
21:15
PACB

Pacific Biosciences

$5.83 /

+0.84 (+16.83%)

Piper Sandler analyst…

Piper Sandler analyst David Westenberg lowered the firm's price target on Pacific Biosciences to $6 from $13 and keeps a Neutral rating on the shares post the earnings release. The analyst dropped price targets in the life science tools and genomics space to reflect movements in comp valuations.

ShowHide Related Items >><<
PACB Pacific Biosciences
$5.83 /

+0.84 (+16.83%)

PACB Pacific Biosciences
$5.83 /

+0.84 (+16.83%)

05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
01/21/22 Cantor Fitzgerald
Pacific Biosciences assumed with an Overweight at Cantor Fitzgerald
PACB Pacific Biosciences
$5.83 /

+0.84 (+16.83%)

PACB Pacific Biosciences
$5.83 /

+0.84 (+16.83%)

PACB Pacific Biosciences
$5.83 /

+0.84 (+16.83%)

Recommendations
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald » 07:44
05/05/22
05/05
07:44
05/05/22
07:44
PACB

Pacific Biosciences

$7.31 /

+0.465 (+6.79%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Ross Osborn lowered the firm's price target on Pacific Biosciences to $19 from $23 and keeps an Overweight rating on the shares following the quarterly results. Given Pacific's "superior" long-read offering, strong cash balance and product pipeline that significantly expands the company's TAM, Osborn encourages investors to take advantage of the company's attractive valuation and acquire shares, the analyst says in a research note.

ShowHide Related Items >><<
PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
01/21/22 Cantor Fitzgerald
Pacific Biosciences assumed with an Overweight at Cantor Fitzgerald
01/11/22 Piper Sandler
Pacific Biosciences has new competitor in Illumina, says Piper Sandler
PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

Earnings
Pacific Biosciences reports Q1 EPS (37c), consensus (31c) » 17:02
05/04/22
05/04
17:02
05/04/22
17:02
PACB

Pacific Biosciences

$7.31 /

+0.465 (+6.79%)

Reports Q1 revenue…

Reports Q1 revenue $33.2M, consensus $32.82M.

ShowHide Related Items >><<
PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
01/21/22 Cantor Fitzgerald
Pacific Biosciences assumed with an Overweight at Cantor Fitzgerald
01/11/22 Piper Sandler
Pacific Biosciences has new competitor in Illumina, says Piper Sandler
PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

PACB Pacific Biosciences
$7.31 /

+0.465 (+6.79%)

Hot Stocks
Pacific Bioscience releases new update to its HiFi sequencing technology » 09:15
04/21/22
04/21
09:15
04/21/22
09:15
PACB

Pacific Biosciences

$7.01 /

-0.42 (-5.65%)

PacBio announced the…

PacBio announced the release of a transformative capability to detect DNA methylation using the Sequel IIe and Sequel II Systems. This extends PacBio's HiFi sequencing technology to now include access to the epigenome, a second layer of genomic information often left unexplored due to fundamental limitations of common sequencing technologies. PacBio's single-molecule approach provides a much more holistic view of molecular behavior during sequencing. This update also includes a wide range of workflow improvements to enhance customer experience, such as simplified, unified, and accelerated library preparation workflows and consumables, live instrument performance monitoring, and on-instrument analysis support for recombinant adeno-associated virus genome sequencing. "With each product release we continue to improve the utility and value of the Sequel II and IIe platform, providing researchers with unique capabilities that differentiate PacBio HiFi sequencing from all other sequencing technologies," said Christian Henry, President and Chief Executive Officer of PacBio. "Our latest enhancements to the Sequel II and IIe platform, including 5-base sequencing and improved workflows are expected to both simplify the ability to generate high quality data and enable deeper insights into the complexity of the genome."

ShowHide Related Items >><<
PACB Pacific Biosciences
$7.01 /

-0.42 (-5.65%)

PACB Pacific Biosciences
$7.01 /

-0.42 (-5.65%)

03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
02/16/22 Canaccord
Pacific Biosciences price target lowered to $40 from $45 at Canaccord
01/21/22 Cantor Fitzgerald
Pacific Biosciences assumed with an Overweight at Cantor Fitzgerald
01/11/22 Piper Sandler
Pacific Biosciences has new competitor in Illumina, says Piper Sandler
PACB Pacific Biosciences
$7.01 /

-0.42 (-5.65%)

PACB Pacific Biosciences
$7.01 /

-0.42 (-5.65%)

PACB Pacific Biosciences
$7.01 /

-0.42 (-5.65%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.